Jwa Hyeon Seok, Kim Yong Ho, Lee Jaehee, Back Seung-Keun, Park Chul-Kyu
Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon 21999, Republic of Korea.
Gachon Pain Center and Department of Physiology, Gachon University College of Medicine, Incheon 21999, Republic of Korea.
Stem Cells Int. 2020 Oct 12;2020:8845262. doi: 10.1155/2020/8845262. eCollection 2020.
Neuropathic pain caused by lesions or nervous system dysfunction is a neuroimmune disease with limited therapeutic options. Adipose tissue-derived stem cells (ASCs) are multipotent mesenchymal stem cells with potent immunosuppressive properties, and their use as novel cell-based therapeutics have been proposed in many immune diseases. However, the analgesic effect and efficacy of ASCs to treat neuropathic pain remain unclear. This study, thus, investigated whether ASCs or ASC-derived culture medium can relieve neuropathic pain behaviors (i.e., mechanical and cold allodynia) in a rat model with L5 spinal nerve ligation. Intrathecal injection of ASCs significantly reduced cold allodynia, but not mechanical allodynia. Importantly, cold allodynia was completely reversed in rats with repeated injections of ASCs. In contrast, intrathecal injection of ASC-derived culture medium or -orbital injection of ASCs had no effect on neuropathic pain behaviors. These results suggest a novel and alternative therapeutic application of ASCs to target specific neuropathic pain behaviors.
由病变或神经系统功能障碍引起的神经性疼痛是一种治疗选择有限的神经免疫疾病。脂肪组织来源的干细胞(ASC)是具有强大免疫抑制特性的多能间充质干细胞,在许多免疫疾病中已有人提出将其用作新型的基于细胞的治疗方法。然而,ASC治疗神经性疼痛的镇痛效果和疗效仍不清楚。因此,本研究调查了ASC或ASC衍生的培养基是否能缓解L5脊神经结扎大鼠模型中的神经性疼痛行为(即机械性和冷觉异常性疼痛)。鞘内注射ASC可显著减轻冷觉异常性疼痛,但对机械性异常性疼痛无效。重要的是,重复注射ASC的大鼠冷觉异常性疼痛完全得到逆转。相比之下,鞘内注射ASC衍生的培养基或眼眶注射ASC对神经性疼痛行为没有影响。这些结果表明ASC在针对特定神经性疼痛行为方面有新的替代治疗应用。